株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

IVD(体外診断)アプリケーションにおけるフローサイトメトリーの世界市場

The World Market for Flow Cytometry in IVD Applications

発行 Kalorama Information 商品コード 306994
出版日 ページ情報 英文 40 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
IVD(体外診断)アプリケーションにおけるフローサイトメトリーの世界市場 The World Market for Flow Cytometry in IVD Applications
出版日: 2014年06月16日 ページ情報: 英文 40 Pages
概要

フローサイトメーターは強力な参照試験所装置であり、現在では先進国における最新のIVD試験所の重要な構成要素となっています。癌の診断に用いられるほか、臨床における新たな応用としてHIV検査やモニタリングに用いられています。これまではフローサイトメトリーの用途は限られていましたが、今後他の分野にも応用されるとみられています。

当レポートでは、体外診断におけるフローサイトメトリーについて調査し、今後の市場予測、応用別、地域別動向、参入企業の市場シェアを製品概要、およびプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • フローサイトメトリーとは
  • 処置件数
  • 競合技術
    • 免疫組織化学的染色
    • 蛍光in situハイブリッド化
    • 血液学システム
    • 即時CD4検査
  • CMS支払改訂
  • 合併・買収
  • 応用:癌
    • リンパ腫
    • 非ホジキンリンパ腫
    • ホジキンリンパ腫
  • フローサイトメトリーの使用
    • 肺癌
    • 前立腺癌
  • 応用:HIV
  • 応用:臓器移植
  • 企業別製品
    • Becton Dickinson
    • Beckman Coulter
    • EMD Millipore
    • Miltenyi Biotec
    • Partec
    • Sony Biotechnology/ iCyt

第3章 市場分析

  • 市場規模
  • 用途別市場
  • 地域別市場
  • 国別フローサイトメトリー市場
  • 市場シェア

第4章 企業プロファイル

  • Beckman Coulter
  • Becton, Dickinson and Company
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology (iCyt)

図表

目次
Product Code: KLI5271977

Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications included the commercialization and refinement of HIV testing and monitoring through CD4/CD8 counts. Until recently flow cytometry has been used exclusively for these purposes. Other applications are seeing procedure growth.

This report, The World Market for Flow Cytometry in In Vitro Diagnostic Applications, is Kalorama's complete market analysis of this important diagnostics segment.

  • Market and Forecast 2013-2018 for Flow Cytometry in IVD
  • Breakout by Application (Cancer, HIV, Organ Transplant, Other)
  • Regional Breakout (US, EUR, ROW)
  • Country Markets for Flow Cytometry
  • Market Share by Company
  • Products on the Market
  • Key Company Profiles

Flow cytometry is useful in biotechnology, drug development, and clinical research. This report focuses only on IVD applications for flow. As part of its analysis, Kalorama considers growth drivers for the flow cytometry market in diagnostics, examines competitive moves by companies in the market, and reimbursment trends that will affect growth long-term. Profiled manufacturers include:

  • Beckman Coulter
  • Becton, Dickinson
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology ( iCyt )

Additional Information

Kalorama Sees Static Competition in Flow Cytometry Despite New Entrants.

For years, the flow cytometry market has been a battle between Becton Dickinson and Beckman Coulter. And despite the entry of Sysmex and Sony Technology into the market, Kalorama Information doesn't expect that to change. These two terms should fight primarily for the $1,115. The finding was made in the firm's latest market research report. The World Market for Flow Cytometry.

“The two main firms hold 90% plus of the market,” said Bruce Carlson, Publisher of Kalorama Information. “As both the major firms continue to grow by innovation and acquisition, it is not likely that a firm will challenge significant market share of the two largest players in the short term.”

The report presents Kalorama's estimation of the market share for flow cytometry. Two main competitors dominate the market for these systems. BD is the clear leader of the flow cytometry market. BD continues to update its systems and test kits to maintain complete dominance of this market. Beckman Coulter is estimated to have a 22% share of the market. Beckman has made strategic acquisitions to be sure they are on the cutting edge of cytometry.

In recent years, some new competitors entered the market. EMD Millipore, owned by Merck, and Sony technologies, operating through iCyt subsidiary, have developed reputable cytometers. Most recently, Görlitz-based biotechnology and diagnostics company Partec GmbH signed up with Sysmex Corporation based in Kobe, Japan. Partec products will now be distributed worldwide under the Sysmex umbrella. Sysmex is a leading international supplier of in vitro diagnostic products, with annual sales in excess of 1.2 billion euros. Where Partec was previously active in 140 countries, it now has access to a distribution network for 60 additional countries.. Partecs HIV/AIDS, tuberculosis and malaria diagnostic products for emerging countries could see better distribution.

CMS PAYMENT REVISIONS

In July 2013, the Centers for Medicare and Medicaid Services (CMS) announced its proposed rule with regard to payment revisions under the 2014 Physician Fee Schedule (PFS) and Clinical Laboratory Fee Schedule (CLFS). The rule states that the real cost for high complexity testing such as flow cytometry in hospital laboratories can be collected from calculations based on aggregate payments by the CMS to hospitals under bundled care. However, the estimated amounts are lower than the actual costs of this testing when done in both hospitals and independent laboratories. Kalorama estimates that the implementation of the rule will lead to further drastic cuts in laboratory reimbursements. Hospital-based flow cytometry laboratories are consequently sponsored by their parent bodies, while independent laboratories depend on the actual revenues for their survival. In addition, according to this rule, the CMS slashed clinical pathology technical codes up to 75% for common services such as flow cytometry, immunohistochemistry, and fluorescence in situ hybridization. This was because the CMS considers these prices as “misvalued codes on the physician fee schedule.”

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Size and Growth of the Market
  • Conclusions

TWO: INTRODUCTION

  • About Flow Cytometry
  • Procedure Volume
  • Competitive Technologies
  • Immunohistochemical Stains (IHC)
  • Fluorescent in situ Hybridization (FISH)
  • Hematology Systems
  • Rapid CD4 Testing
  • CMS Payment Revisions
  • Mergers and Acquisitions
  • Applications - Cancer
  • Lymphomas
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Use of Flow Cytometry
  • Liver Cancer
  • Use of Flow Cytometry
  • Prostate Cancer
  • Use of Flow Cytometry
  • Applications -HIV
  • Applications - Organ Transplantation
  • Products by Company
  • Becton Dickinson
  • Beckman Coulter
  • EMD Millipore
  • Miltenyi Biotec
  • Partec
  • Sony Biotechnology/ iCyt

THREE: MARKET ANALYSIS

  • Market Size
  • Market by Application Area
  • Market by Geographic Area
  • Flow Cytometry Market by Country
  • Market Share
  • FOUR: COMPANY PROFILES
  • Beckman Coulter
  • Becton, Dickinson and Company
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology ( iCyt )

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: World Flow Cytometry Market, 2013-2018

TWO: INTRODUCTION

  • Figure 2-1: World Flow Cytometry Procedures (Comparison to ISH testing),2012-2018
  • Figure 2-2: Cancer Incidence, Worldwide, by Cancer Type

THREE: MARKET ANALYSIS

  • Figure 3-1: World Flow Cytometry Market, 2013-2018
  • Figure 3-2: The Portion of the Flow Cytometry Market Occupied by Cancer Testing,Infectious Disease Testing, Organ Transplant, and Other, 2013-2018
  • Figure 3-3: Regional Sales of Flow Cytometry Equipment and Reagents(U.S., Europe, Rest of World)
  • Figure 3-4: Flow Cytometry Market, 2013, by Country (Germany, France, Italy,China, UK, Spain, Australia, Brazil, Canada, Belgium, Netherlands, Portugal,Mexico, Singapore)
  • Figure 3-5: Estimation of the Current Market Share for Flow Cytometry

FOUR: COMPANY PROFILES

  • Table 4-1: Beckman Coulter Flow Cytometry Segment, 2011-2013
  • Table 4-2: Becton Dickinson Flow Cytometry Segment, 2011-2013
Back to Top